226 related articles for article (PubMed ID: 12746758)
1. Endothelin-1 levels in patients with disorders of the thyroid gland.
Tilly N; Schneider JG; Leidig-Bruckner G; Sommer U; Kasperk C
Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758
[TBL] [Abstract][Full Text] [Related]
2. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
3. Serum interferon gamma levels in autoimmune thyroid disease.
Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
[TBL] [Abstract][Full Text] [Related]
4. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases].
Rink T; Dembowski W; Schroth HJ; Klinger K
Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889
[TBL] [Abstract][Full Text] [Related]
5. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
6. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
7. Increased serum neopterin levels in patients with Graves' disease.
Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D
Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114
[TBL] [Abstract][Full Text] [Related]
8. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
9. A preliminary clinical application of sICAM-1 RIA in three kinds of thyroid disease.
Lu M; Fang P; Zhang Z; He H; Gao S; Hou B; Zheng R; Xiao Q; Yang L
Chin Med J (Engl); 2002 Oct; 115(10):1552-5. PubMed ID: 12490109
[TBL] [Abstract][Full Text] [Related]
10. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease.
Inamo Y; Harada K
J Rheumatol; 1997 Mar; 24(3):576-8. PubMed ID: 9058668
[TBL] [Abstract][Full Text] [Related]
12. The presence of the antigliadin antibodies in autoimmune thyroid diseases.
Akçay MN; Akçay G
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxix-cclxxx. PubMed ID: 15244201
[TBL] [Abstract][Full Text] [Related]
13. A differential association of interferon-gamma high-producing allele T and low-producing allele A (+874 A/T) with Hashimoto's thyroiditis and Graves' disease.
Rekha PL; Ishaq M; Valluri V
Scand J Immunol; 2006 Oct; 64(4):438-43. PubMed ID: 16970687
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
[TBL] [Abstract][Full Text] [Related]
15. Circulating chemokines in patients with autoimmune thyroid diseases.
Domberg J; Liu C; Papewalis C; Pfleger C; Xu K; Willenberg HS; Hermsen D; Scherbaum WA; Schloot NC; Schott M
Horm Metab Res; 2008 Jun; 40(6):416-21. PubMed ID: 18415893
[TBL] [Abstract][Full Text] [Related]
16. Plasmatic endothelin-1 levels in hyperthyroid patients before and after antithyroid therapy.
Cesareo R; Tarabuso A; Di Benedetto M; Lacerna F; Reda G
Minerva Endocrinol; 2000 Mar; 25(1):1-3. PubMed ID: 11148844
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases].
Sawicka B; Bossowski A; Urban M; Szalecki M; Wysocka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Skrzydło M; Rogowski F; Luba M
Pediatr Endocrinol Diabetes Metab; 2009; 15(1):20-7. PubMed ID: 19454185
[TBL] [Abstract][Full Text] [Related]
18. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
[TBL] [Abstract][Full Text] [Related]
19. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
20. An elevation of stem cell factor in patients with hyperthyroid Graves' disease.
Yamada T; Sato A; Aizawa T; Ootsuka H; Miyahara Y; Sakai H; Terao A; Onuma S; Ito Y; Kanamori A; Nakamura Y; Tejima E
Thyroid; 1998 Jun; 8(6):499-504. PubMed ID: 9669287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]